Treatment depleting my-HSCs rejuvenates aged mice immune system
News-Medical.Net — April 1, 2024, 05:00 AM UTC
Summary: Researchers developed a treatment to rejuvenate the immunological system by depleting myeloid-biased hematopoietic stem cells (my-HSCs) in aged mice. This led to increased lymphocyte progenitors, improved immune responses to infections, and reduced levels of pro-inflammatory proteins. The study identified potential targets for therapeutic my-HSC reduction and highlighted the importance of balancing myeloid and lymphoid lineage cells for optimal immune function.
Article metrics
Significance5.7
Scale7.0
Magnitude7.5
Potential8.5
Novelty8.0
Actionability6.0
Immediacy6.5
Positivity9.0
Credibility8.0